[1]
A. R. Kulyk, “INFLUENCE OF DULOXETINE ON THE CLINICAL COURSE AND BIOCHEMICAL PARAMETERS IN PATIENTS WITH CHRONIC VERTEBROGENIC LUMBOSACRAL PAIN SYNDROMES”, MCCh, no. 3, pp. 30–35, Oct. 2023.